Optimum duration of treatment with 6-mercaptopurine for Crohn's disease

American Journal of Gastroenterology

Volumn 94, Issue 11, 1999, Pages 3254-3257

  Kim, Peter S ^a   Zlatanic, Jusuf ^a   Korelitz, Burton I ^a   Gleim, Gilbert W ^a  

^a LENOX HILL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; IMMUNOMODULATING AGENT; MERCAPTOPURINE; MESALAZINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CROHN DISEASE; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELAPSE; REMISSION;

6-MERCAPTOPURINE; ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AZATHIOPRINE; CONFIDENCE INTERVALS; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MESALAMINE; MIDDLE AGED; PROBABILITY; PROPORTIONAL HAZARDS MODELS; RECURRENCE; REMISSION INDUCTION; SEX FACTORS; TIME FACTORS;

EID: 0032747481     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00591-2     Document Type: Article

References (22)

1. Present D.H., Korelitz B.I., Wisch N., et al. Treatment of Crohn's disease with 6-mercaptopurine. A long term, randomized, double blind study. N Engl J Med. 302:1980;981-987.
2. O'Donoghue D.P., Dawson A.M., Powell-Tuck K., et al. Double-blind withdrawal trial of azathioprine as maintenance treatment of Crohn's disease. Lancet. ii:1978;944-946.
3. Ewe K., Press A.G., Singe C.C., et al. Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease. Gastroenterology. 105:1993;367-372.
4. O'Brien J.J., Bayless T.M., Bayless J.A. Use of azathioprine or 6-mercaptopurine in the treatment of Crohn's disease. Gastroenterology. 101:1991;39-46.
5. Markowitz J., Rosa J., Grancher K., et al. Long-term 6-mercaptopurine treatment in adolescents with Crohn's disease. Gastroenterology. 99:1990;1347-1351.
6. Korelitz B.I., Present D.H. Favorable effect of 6-mercaptopurine on the fistulae of Crohn's disease. Dig Dis Sci. 30:1985;58-64.
7. Present H.P., Meltzer S.J., Krumholz M.P., et al. 6-Mercaptopurine in the management of inflammatory bowel disease: Short- and long-term toxicity. Ann Intern Med. 111:1989;641-649.
8. Lemann M., Bonhomme P., Bitoun A., et al. Traitement de la maladie de Crohn par l'azathioprine ou la 6-mercaptopurine. Etude retrospective chez 126 malades. Gastroenterol Clin Biol. 14:1990;548-554.
9. Korelitz B.I., Fleisher M.R., Burns A.W., et al. Should toxicity to 6MP serve to discourage long term maintenance therapy of IBD? Experience of the past quarter century. Am J Gastroenterol. 91:1996;A665.
10. Lennard-Jones J.E., Miscewicz J.J., Connell A.M., et al. Prednisone as a maintenance treatment for ulcerative colitis in remission. Lancet. 1:1965;180.
11. Sparberg M., Kirsner J.B. Long term corticosteroid therapy for regional enteritis. Am J Dig Dis. 11:1966;865-880.
12. Korelitz B.I., Adler D.J., Mendelsohn R.A., et al. Long-term experience with 6-mercaptopurine in the treatment of Crohn's disease. Am J Gastroenterol. 88:1993;1198-1205.
13. Bouhnik Y., Lemann M., Mary J.-Y., et al. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet. 347:1996;215-219.
14. Harvey R.F., Bradshaw J.M. A simple index of Crohn's-disease activity. Lancet. 1:1980;514.
15. Candy S., Wright J., Gerber M., et al. A controlled double blind study of azathioprine in the management of Crohn's disease. Gut. 37:1995;674-678.
16. Willoughby J.M.T., Kumar P.J., Beckett J., et al. Controlled trial of azathioprine in Crohn's disease. Lancet. ii:1971;944-947.
17. Rosenberg J.L., Levin B., Wall A.J., et al. A controlled trial of azathioprine in Crohn's disease. Dig Dis. 20:1975;721-726.
18. Summers R.W., Switz D.N., Sessions J.T. Jr, et al. National cooperative Crohn's disease study Results of drug treatment . Gastroenterology. 77:1979;847-869.
19. Duffy L.C., Zielezny M.A., Marshall J.R. Cigarette smoking and risk of clinical relapse in patients with Crohn's disease. Am Rev Prev Med. 6:1990;161-166.
20. Sutherland L.R., Ramcharan S., Bryant H., et al. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology. 98:1990;1123-1128.
21. Cottone M., Rosselli M., Orlando A., et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology. 106:1994;643-648.
22. Nyman M., Hansson I., Ericksson S. Long-term immunosuppressive treatment in Crohn's disease. Scand J Gastroenterol. 20:1985;1197-1203.